Eli Lilly bets on recombinases in $2.25bn Profluent R&D pact Pharmaceutical Technology 12:02 Wed, 29 Apr
Lilly Teams Up With Profluent In AI-Powered Gene-Editing Pact Scrip Pharma Intelligence 22:08 Tue, 28 Apr
Eli Lilly, Profluent Target Complex Genetic Diseases With AI-Driven Custom DNA Tools Benzinga 20:08 Tue, 28 Apr Article paywall
Eli Lilly Inks $2.25B AI Genetics Research Pact With Profluent Law360 19:47 Tue, 28 Apr Article paywall
Profluent, Lilly partner in genetic medicine deal worth up to $2.25 billion Channel NewsAsia 12:42 Tue, 28 Apr
Profluent Announces Strategic Partnership with Lilly to Develop AI-Designed Recombinases for Genetic Medicine Business Wire (Press Release) 12:02 Tue, 28 Apr
